Entries by admin

Canada’s GenePOC Expanding to Enter Lab and POC MDx Market Next Year

NEW YORK (from GenomeWeb – Madeleine Johnson) – Canadian firm GenePOC recently expanded its staff and intends to enter the molecular diagnostics market with a Group B Streptococcus assay at the end of the second quarter of 2016 and a Clostridium difficile assay in Q4 2016. The company will initially launch the tests as CE-IVD products in […]

A Quebec City company on the cusp of a revolution in the field of medical diagnosis

A Quebec City company on the cusp of a revolution in the field of medical diagnosis Infectious disease diagnosis made fast and easy with GenePOC technology Quebec City, February 11th, 2015 – It will soon be possible to diagnose and identify Clostridium difficile, Staphylococcus, Streptococcus, respiratory tract infections, sexually transmitted infections, and a variety of […]

A revolutionary microfluidic stand-alone platform (GenePOC) for nucleic-acid based point-of-care diagnostics

GenePOC  in Global Point of Care, Strategies for Disasters, complex emergencies, and Public Health crises: Enhancing Standards of care at the site of need. AACC Press, Washington, DC, Kost G and C Corbin (eds) Bissonnette L, S Chapdelaine, R Peytavi, A Huletsky, G Stewart, M Boissinot, P Allibert, and MG Bergeron (2014). A revolutionary microfluidic stand-alone […]

GenePOC in Insight BIOTECanada

The Future of Personalized Medecine Patrice Allibert, PhD., Chief Executive Officier GenePOC answers to Insight BIOTECanada Interview See full text

GenePOC is now installed in its new State of the Art facility

GenePOC is now located in the Technological Park in Quebec City. The State of the Art facility is equiped with ISO 7 clean rooms to install  the molecular development of assays and the manufacturing of its disposable. GenePOC, 360 Rue Franquet, Suite #100, Québec G1P 4N3, Canada